MCIA Inc boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 1.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,786 shares of the healthcare conglomerate’s stock after acquiring an additional 50 shares during the period. UnitedHealth Group comprises 1.0% of MCIA Inc’s holdings, making the stock its 24th biggest position. MCIA Inc’s holdings in UnitedHealth Group were worth $2,035,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also modified their holdings of UNH. Outfitter Financial LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $25,000. Blue Bell Private Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $29,000. Advocacy Wealth Management Services LLC raised its position in shares of UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 25 shares in the last quarter. Cascade Investment Advisors Inc. grew its holdings in shares of UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 30 shares during the last quarter. Finally, Tortoise Investment Management LLC grew its holdings in shares of UnitedHealth Group by 54.8% during the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 23 shares during the last quarter. Institutional investors and hedge funds own 87.48% of the company’s stock.
UNH has been the topic of several research reports. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $570.00 to $577.00 and gave the company an “overweight” rating in a report on Monday, April 18th. Royal Bank of Canada set a $563.00 target price on shares of UnitedHealth Group and gave the stock an “outperform” rating in a report on Monday, April 18th. Barclays boosted their target price on shares of UnitedHealth Group from $495.00 to $565.00 and gave the stock an “overweight” rating in a report on Wednesday, March 30th. BMO Capital Markets boosted their target price on shares of UnitedHealth Group from $510.00 to $600.00 and gave the stock a “market perform” rating in a report on Tuesday, April 19th. Finally, Cowen boosted their target price on shares of UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $555.73.
UnitedHealth Group (NYSE:UNH – Get Rating) last released its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, topping the consensus estimate of $5.40 by $0.09. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The firm had revenue of $80.15 billion for the quarter, compared to the consensus estimate of $78.77 billion. During the same quarter in the prior year, the company posted $5.31 earnings per share. The business’s revenue was up 14.2% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 21.75 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th will be issued a dividend of $1.65 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date is Thursday, June 16th. This represents a $6.60 annualized dividend and a yield of 1.35%. UnitedHealth Group’s dividend payout ratio is presently 36.12%.
In other news, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total value of $1,197,400.00. Following the completion of the sale, the director now owns 1,215,000 shares in the company, valued at approximately $581,936,400. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Frederick William Mcnabb III purchased 89 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 26th. The shares were bought at an average price of $504.32 per share, with a total value of $44,884.48. Following the transaction, the director now owns 11,259 shares of the company’s stock, valued at approximately $5,678,138.88. The disclosure for this purchase can be found here. Corporate insiders own 0.40% of the company’s stock.
UnitedHealth Group Company Profile (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Victoria’s Secret Stock is Out of the Box
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.